NewEdge Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,230	Closed	-$89.2K	–	3621
2023 Q2	$89.2K	Buy	+3,230	New	+$89.2K	﹤0.01%	1885